Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
for Neurofibromatosis Type 2
6 locations incl. Los Angeles
Sponsor: Scott R. Plotkin, MD, PhD
Sex: All·Age: 12+
Code: NCT04374305·Phase 2·Recruiting